Review of the Roles and Interaction of Androgen and Inflammation in Benign Prostatic Hyperplasia.

Mediators of Inflammation
Yu Tong, Ren-Yuan Zhou

Abstract

The lower urinary tract symptoms (LUTSs) and acute urinary retention (AUR) caused by benign prostatic hyperplasia (BPH) can seriously affect the quality of life of elderly men. Studies suggest that both androgens and inflammation greatly influence the occurrence and development of BPH in most patients. These two factors combined can also affect each other, leading to pathological changes in the stromal and epithelial tissue of the prostate transition zone in BPH patients. DHT in the prostate tissue of BPH patients may activate a chronic inflammatory response in the prostate, amplifying the expression of inflammatory factors and upregulating the proliferation ability of prostate tissue.

References

Jan 1, 1990·International Urology and Nephrology·I SasagawaT Katayama
Apr 25, 2001·Clinical Endocrinology·B JinD J Handelsman
Sep 28, 2002·Urology·Claus G RoehrbornUNKNOWN ARIA3001 ARIA3002 and ARIA3003 Study Investigators
Dec 19, 2003·The New England Journal of Medicine·John D McConnellUNKNOWN Medical Therapy of Prostatic Symptoms (MTOPS) Research Group
Mar 2, 2006·BJU International·Claus G Roehrborn
Aug 15, 2006·American Journal of Epidemiology·Jennifer L St SauverSteven J Jacobsen
Dec 22, 2006·European Urology·Gero KramerMichael Marberger
Jul 10, 2007·European Urology·Alessandro SciarraVincenzo Gentile
Nov 13, 2008·International Journal of Impotence Research·C G Roehrborn
Aug 12, 2009·The Prostate·Grégoire RobertAlexandre de la Taille
Nov 29, 2011·European Urology·Cosimo De NunzioJ Kellogg Parsons
Jun 21, 2012·International Journal of Andrology·A A QuintarC A Maldonado
Aug 23, 2012·Molecular Carcinogenesis·Bilge Debelec-ButunerKemal Sami Korkmaz
Jan 3, 2013·Journal of Cellular Physiology·Carolina LeimgruberCristina Alicia Maldonado
Jun 25, 2013·Differentiation; Research in Biological Diversity·Tristan M NicholsonWilliam A Ricke
Jul 12, 2014·European Urology·Alexandre R ZlottaTheodorus van der Kwast
Dec 3, 2014·European Urology·Andrea TubaroFabrizio Presicce
Sep 24, 2015·Prostate Cancer and Prostatic Diseases·Q HeS Gupta
Dec 31, 2015·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Teemu J MurtolaElizabeth A Platz
May 3, 2016·The Urologic Clinics of North America·Joseph P Alukal, Herbert Lepor
May 14, 2016·The Journal of Clinical Endocrinology and Metabolism·Arthi ThirumalaiStephanie T Page
Oct 1, 2016·Nature Reviews. Urology·Cosimo De NunzioAndrea Tubaro
Aug 24, 2017·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Michael B CookAnn W Hsing
Aug 20, 2019·BJU International·Carolyn A Salter, John P Mulhall
Aug 21, 2019·The Journal of Urology·Charles WelliverUNKNOWN Urologic Diseases in America Project

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsies
PLESS
biopsy

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.